Date: June 2nd – June 5th, 2022

Jio World Centre
Bandra Kurla Complex, Bandra East, Mumbai

The society organises annual conferences in different parts of the country. In these conferences, a number of scientific activities that include instruction courses, symposia, lectures, post graduate refresher courses, booth lectures, wet labs, surgical skill transfer courses etc. are conducted for the promotion and mutual exchange of knowledge in the field of ophthalmic science.

The society also gives incentives to the members in the form of awards, orations, prizes and Fellowships in recognition of their services in the various specialties.

Click the link below to learn more and to register:

Date: September 28th–29th, 2022

IMPORTANT DATES
Jan 3 – Abstract Submissions Open for Scientific Papers and Electronic Posters
April 15 – Deadline for Abstract Submissions
May 3 – Early Registration Deadline
Jul 31 – Program Preview Available Online
Aug 12 – Advance Registration Deadline
Sept 28–29 – World Cornea Congress VIII

For more details visit the World Cornea Congress website

Date: September 16th-20th, 2022

We are pleased to inform you that the 40th Congress of the ESCRS will take place at the MiCo Milano Convention Centre, Milan, Italy from Friday 16 to Tuesday 20 September 2022.
The Congress will be a primarily face-to-face event, supported by a number of virtual elements. ESCRS is proud to have been among the first international healthcare societies to return to “live” meetings in 2021 and is excited to continue in this direction in 2022.

Registration information will be released here soon.

For more details visit the ESCRS website

March 11th, 2022

Canadian Ophthalmological Society (COS)and Canadian Retina Society (CRS) Joint Position Statement on Polysulfate Sodium (Elmiron)

Pentosan Polysulfate sodium (PPS), also known as Elmiron, is an oral medication prescribed for the treatment of interstitial cystitis (IC). PPS has been used to treat IC since 1996.

A dose-related progressive retinal maculopathy is associated with the use of PPS. The retinal changes from PPS include macular edema, choroidal neovascularization and retinal pigment epithelial hyperpigmentation followed by atrophy. Severe vision loss is associated with late PPS maculopathy.

An article, entitled Re-visioning by Carol Yaple, which was included in the CMAJ, Vol. 194, Issue 97 Mar 2022

“On Dec. 1, 2011, I received a diagnosis of Stargardt disease, an inherited retinal disorder that affects central vision. Genetic testing showed that my mother carried the mutation, and my father contributed a common variant. One in 10 000 are afflicted with this rare condition, which often presents in childhood.”

Read the Full Article here:

Date: Tuesday, March 8th, 2022
Time: 8:00 – 9:00 pm ET

Imagine a gender equal health system. One that is free of bias towards women physicians, medical learners, health workers and patients. We must eliminate the double standard, and level the playing field. What would that look like? What could be achieved? Join Canada’s top women in medicine as they share their experience and discuss how to #BreakTheBias.

Moderated by: Dr. Katharine Smart, President, Canadian Medical Association

Dr. Gigi Osler, President, Federation of Medical Women of Canada

Dr. Modupe Tunde-Byass, President, Black Physicians of Canada

Dr. Deidre Young, President, Canadian Women in Medicine

Dr. Sarah Funnell, Founding Director, Centre for Indigenous Health Research and Education

Dr. Joanne Liu, Former President, Doctors Without Borders International

Click the link below to register:

This is a special supplement entitled Dialogues in Dry Eye focusing on perspectives and insights in the management of dry eye and ocular surface disease.

Learn more here:

February 16th, 2022

The Canadian Ophthalmological Society (COS) embraces inclusivity and opposes discrimination based on (but not limited to) religion, race, citizenship, country or ethnic origin, language, age, political affiliation, sex, sexual orientation, gender identity and expression, cognitive or physical ability, and economic status. As the recognized unified voice for ophthalmology in Canada, COS is strengthened by its diversity, and the COS is committed to being a leader in equity, diversity and inclusion in ophthalmology. COS members come from broad and diverse backgrounds, and this variety of experiences, training, and personal qualities is fundamental to a physician’s ability to provide the highest quality and culturally competent care for all patients.

Date: Wednesday, February 9th, 2022

Time: 8:30 pm

Topic: AAO/AAPOS February 2022 Journal Club

Moderator: Dr. Ken Wright

Validation of a novel strabismus surgery 3D-printed silicone eye model for simulation training – Yi Ning Strube, MD

Increasing incidence and risk factors for divergence insufficiency esotropia – David L. Guyton, MD

Long-term ophthalmic outcomes in 120 children with unilateral coronal synostosis: A 20-year retrospective analysis – Linda R. Dagi, MD

Register here: